A proposal floated Tuesday by outgoing President Joe Biden to require Medicare and Medicaid to offer coverage for prescriptions of popular but expensive injectable weight loss drugs had the tentative ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.

Physician and economist Jay Bhattacharya has been selected by Donald Trump to lead the National Institutes of Health.

Biden's new proposal would significantly expand access to anti-obesity drugs such as Ozempic and Wegovy. Without insurance coverage, the drugs can cost as much as $1,000 a month. Lawmakers previously ...

Nonmainstream doctors and health leaders are wielding serious muscle in shaping the incoming administration’s health policies ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Share on Facebook Share on Twitter Under a new rule the Biden administration proposed on Tuesday, millions of Americans with ...

President-elect Donald Trump reached a required agreement to allow his transition staff to coordinate with the existing ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

The Department of Health and Human Services seeks to expand when Medicare and Medicaid can cover anti-obesity drugs, such as ...